- ►nih.gov RJ Bodnar - Peptides, 2007 - Elsevier This paper is the 29th consecutive installment of the annual review of research concerning the
endogenous opioid system, now spanning 30 years of research. It summarizes papers published
during 2006 that studied the behavioral effects of molecular, pharmacological and genetic ... Cited by 20 - Related articles - All 4 versions
E Meaney, A Vela, V Samaniego, A Meaney, J … - Clinical & Experimental …, 2008 - pt.wkhealth.com 1. Metabolic syndrome (MS) is one of the greatest public health problems in Mexico, where more
than 75% of adults in urban populations are overweight or obese. Metabolic syndrome has several
comorbidities, which result in a high cardiometabolic risk. Cited by 6 - Related articles - All 5 versions
HN Mistri, AG Jangid, PS Shrivastav - Journal of Pharmaceutical and Biomedical …, 2007 - Elsevier A simple and rapid liquid chromatography/tandem mass spectrometry (LC–MS/MS) method has
been developed and validated for the simultaneous quantitation of antidiabetic drugs metformin
and glyburide in human plasma using glimepiride as internal standard (IS). After acidic ... Cited by 5 - Related articles - All 3 versions
NR Hill, DR Matthews - Drugs Today, 2007 - journals.prous.com Combination therapy of two or more agents to control glycemia in type 2 diabetes is now widely
used in clinical practice. Such oral agents are best combined where their modes of action are
complementary, and where side effects will not be exacerbated. Logical combinations ... Cited by 3 - Related articles - All 4 versions
R Barazzoni, M Zanetti, MR Cattin, L Visintin, P Vinci, L … - Obesity, 2007 - nature.com Objective: Ghrelin administration can induce fat weight gain and hyperglycemia (potentially through
ghrelin-induced hepatic glucose production), but plasma ghrelin is positively associated with
whole-body insulin sensitivity (mainly reflecting muscle insulin action) being increased in ... Cited by 4 - Related articles - All 2 versions
VY Waisundara, A Hsu, D Huang, BK Tan - AMERICAN JOURNAL OF …, 2008 - jn.wspc.com.sg Abstract: Oxidative stress is the root cause of diabetic macro- and microvascular
complications. Biochemical and epidemiological studies indicate that current treatments for diabetes
do not reduce risks of developing complications, suggesting their inability to alleviate the ... Cited by 2 - Related articles - BL Direct - All 4 versions
Z Liu, J Li, Z Zeng, M Liu, M Wang - Chemico-Biological Interactions, 2008 - Elsevier In this paper, the antidiabetic effects of cysteinyl metformin (CM), a newly synthesized agent,
were investigated to evaluate the hypoglycemic/hypolipidemic effects by measuring blood
glucose, triglyceride and insulin levels in CM- and metformin-treated diabetic rats. Two ... Cited by 1 - Related articles - All 3 versions
CH Su, IM Liu, HH Chung, JT Cheng - Neuroscience Letters, 2009 - Elsevier In an attempt to clarify the role of endogenous opioid in peripheral I 2 -imidazoline receptors
activation for improvement of insulin action, bilateral adrenalectomy was carried out in rats with
insulin resistance induced by 4-week fructose-rich chow feeding. Single intravenous (iv) ... Related articles - All 2 versions
A Tahara, A Matsuyama-Yokono, R … - Basic & Clinical …, 2008 - interscience.wiley.com Abstract: In this study, streptozotocin-induced severely diabetic rats and
streptozotocin-nicotinamide-induced mildly diabetic rats were established to compare their characteristics
and to investigate the hypoglycaemic effects of antidiabetic drugs. Results show that in ... Cited by 1 - Related articles - All 4 versions
S Zervou, M Khan - Vascular Disease Prevention, 2007 - ingentaconnect.com The available therapeutic agents with the strongest current evidential support in prevention of
CVD in diabetes are not those which primarily reduce blood glucose levels but rather those which
reduce low density lipoprotein cholesterol or blood pressure. Current results from clinical ... Related articles - BL Direct
